Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes.

MLA

Mistretta, Francesco A., et al. “Adherence to Guideline Recommendations for Multimodality Treatment of Patients with PT2-3 M0 Non-Urothelial Carcinoma of the Urinary Bladder: Temporal Trends and Survival Outcomes.” International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 27, no. 5, May 2020, pp. 402–07. EBSCOhost, https://doi.org/10.1111/iju.14206.

APA

Mistretta, F. A., Negrean-Dzyuba, C., Palumbo, C., Pecoraro, A., Knipper, S., Tian, Z., Musi, G., Montanari, E., Perrotte, P., Briganti, A., Shariat, S. F., Saad, F., de Cobelli, O., & Karakiewicz, P. I. (2020). Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes. International Journal of Urology : Official Journal of the Japanese Urological Association, 27(5), 402–407. https://doi.org/10.1111/iju.14206

Chicago

Mistretta, Francesco A, Cristina Negrean-Dzyuba, Carlotta Palumbo, Angela Pecoraro, Sophie Knipper, Zhe Tian, Gennaro Musi, et al. 2020. “Adherence to Guideline Recommendations for Multimodality Treatment of Patients with PT2-3 M0 Non-Urothelial Carcinoma of the Urinary Bladder: Temporal Trends and Survival Outcomes.” International Journal of Urology : Official Journal of the Japanese Urological Association 27 (5): 402–7. doi:10.1111/iju.14206.